Study Stopped
It was a pilot study and we enrolled sufficient numbers to evaluate the proposed outcomes.
Assessing Alternative Approaches for Blood Pressure Control: A3BC Trial
1 other identifier
interventional
32
1 country
1
Brief Summary
An estimated 76 million adults in the United States over the age of 20 have hypertension (HTN); which translates into 1 out of 3 adults. Globally the prevalence of HTN is over 25% for adults, and accounts for approximately 13.5% of all deaths. Given the aging of the population together with increases in obesity and sedentary behavior, it is not surprising that HTN is projected to increase significantly over the next several decades; with over 1.5 billion adults having HTN by the year 2025. Thus the public health implications to preventing and/or reducing elevations in blood pressure are substantial. This study compares the efficacy of two different non-pharmacologic interventions (device guided breathing and isometric hand grip exercises) used alone and in combination for lowering blood pressure. This pilot study will include 30 adults with stage 1 hypertension. The primary outcome is the change in blood pressure from baseline to 8 weeks. Secondary outcomes include change in blood pressure from 8 weeks to 16 weeks and acceptability of the interventions by participants. The knowledge gained from this study can provide information on non-pharmacologic methods that may be useful in decreasing blood pressure. Such knowledge may be especially useful for patients for whom access to medications and health care is limited and among patients unwilling to take or intolerant to pharmacologic therapies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Sep 2014
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2014
CompletedFirst Posted
Study publicly available on registry
April 10, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedResults Posted
Study results publicly available
March 28, 2017
CompletedMarch 28, 2017
February 1, 2017
11 months
April 7, 2014
February 7, 2017
February 7, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Blood Pressure
Blood pressure was measured using an automated cuff with subject in a seated position for at least 5 minutes. Six measurements were recorded at 1-minute intervals. The mean was used in analysis.
8 weeks and 16 weeks
Secondary Outcomes (2)
Adherence to Single Modality Exercise (Device Guided Breathing or Isometric Hand Grip)
8 weeks
Adherence to Dual Modality Exercise (Device Guided Breathing + Isometric Hand Grip)
8 weeks
Study Arms (2)
Device Guided Breathing/Combination Therapy
ACTIVE COMPARATORParticipants will first do device guided breathing for 8 weeks, followed by 8 weeks of doing BOTH the device guided breathing AND the hand grip exercises. Participants will be given a home blood pressure monitor. Participants will measure blood pressure and heart rate at home for 2 weeks prior to starting any intervention and also during the 16 week of intervention.
Isometric Hand Grip/Combination Therapy
ACTIVE COMPARATORParticipants will first do isometric hand grip exercises for 8 weeks, followed by 8 weeks of doing BOTH the device guided breathing AND the hand grip exercises. Participants will be given a home blood pressure monitor. Participants will measure blood pressure and heart rate at home for 2 weeks prior to starting any intervention and also during the 16 week of intervention.
Interventions
Participants will use a device called RESPeRATE which will measure how many breaths they take per minute. A strap wraps around the participants chest that measures breathing frequency. Headphones plug into the device to inform participants about their breathing. The device will help guide participants to breathe slowly using musical tones, with a goal of about ten breaths per minute. Participants will use the breathing device 5 days per week for about 15 minutes each day. Participants will keep a log of their exercises and return it with each visit.
Participants will use a device called the Zona Plus, which they will hold in their hand and squeeze. A session consists of 2 minutes of squeezing the device followed by 1 minute of rest. Participants will do a total of 4 sessions (2 sessions for each hand) for a total of about 12 minutes of exercise. Participants will do these exercises 5 days per week. Participants will keep a log of their exercise and return it with each visit.
Eligibility Criteria
You may qualify if:
- Are at least 21 years old, and
- Have Stage 1 high blood pressure. (Defined as a systolic blood pressure between 140 mm Hg and 159 mm Hg (the top blood pressure number) and/or a diastolic blood pressure between 90 mm Hg and 99 mm Hg (the bottom blood pressure number) in the prior 6 months.)
You may not qualify if:
- Take drugs to control blood pressure.
- Have a history of left ventricular hypertrophy.
- Have a history of cardiovascular disease such as stroke, mini-strokes, heart attack, unstable angina, bypass surgery, stents, angioplasty, abnormal heart rhythms, heart failure, or peripheral artery disease.
- Have diabetes.
- Have a history of poor kidney function.
- Have an upper arm circumference greater than 17 inches.
- Are currently participating in a formal exercise or weight loss program.
- Plan to participate in a formal exercise or weight loss program in the next 6 months.
- Are pregnant or plan to become pregnant in the next 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48106, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
small sample size
Results Point of Contact
- Title
- Dr. Elizabeth Jackson
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth A Jackson, MD MPH FACC
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 7, 2014
First Posted
April 10, 2014
Study Start
September 1, 2014
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
March 28, 2017
Results First Posted
March 28, 2017
Record last verified: 2017-02